Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
Introduction: Peptide-receptor radionuclide therapy (PRRT) has demonstrated its efficacy and safety in a number of clinical trials and has become widely used in the treatment of patients with neuroendocrine neoplasms (NEN) expressing somatostatin receptors.
Conference:
Presenting Author: Baranova O
Authors: Baranova O, Geliashvili T, Markovich A, Zhulikov Y, Evdokimova E,
Keywords: NET, PRRT, 177Lu-DOTATATE,
Introduction: Currently, the incidence of gastric neuroendocrine neoplasia (gNEN) has increased significantly. Most gNEN are developed on the background of chronic atrophic gastritis (about 90%). Despite this, the role of chronic atrophic gastritis treatment (gastroprotective therapy) in dynamic of gNEN remains unexplored.
Conference:
Presenting Author: Konyakhina A
Authors: Konyakhina A, Feidorov I, Salimgereeva D, Petrova A,
Keywords: gNEN, atrophic gastritis, OLGA, rebamipide,
Introduction: Accessibility of high-precision imaging dramatically increased detection rate of small asymptomatic pancreatic neuroendocrine tumors (PanNETs). Functioning status is indication for surgical treatment with high perioperative risks, while increased level of NET markers could be associated with gastric mucosa atrophy or intake of proton pump inhibitors (PPI) and nor with tumor secretion.
Conference:
Presenting Author:
Authors: Salimgereeva D, Feidorov I, Konyakhina A,
Keywords: PanNET, chronic atrophic gastritis, marker, OLGA, anti-parietal cell antibodies,
Introduction: Worldwide frequency of neuroendocrine tumors increased, which is associated with improved approaches to the diagnosis of chronic diseases of the upper digestive tract. Management of these neoplasms in real clinical practice can be difficult.
Conference:
Presenting Author: Konyakhina A
Authors: Konyakhina A, Feidorov I, Salimgereeva D,
Keywords: gNEN, atrophic gastritis, OLGA, rebamipide,
#3553 Gamma-glutamyltransferase as an indicator of hepatic tumor burden in neuroendocrine tumors
Introduction: In patients with neuroendocrine tumors (NETs) and liver metastasis, elevation of gamma-glutamyltransferase (GGT) is considered to be a sign of hepatic progression. However, there are no data supporting this assumption.
Conference:
Presenting Author: Schmidt B
Authors: Schmidt B, Leiderer M, Amin T, Viol F, Adam G,
Keywords: gamma glutamyltransferase, hepatic tumor burden, neuroendocrine tumor, liver metastasis, biomarker,